$OGEN 4 SEC Filings

Filed On	Filing
07 Jul 2026	Form 4: Spencer John, Chief Financial Officer Granted 55,900 Employee Stock Option (right to buy)
15 Dec 2025	Form 4: Huffman Janet, CEO and CFO Granted 250,000 Employee Stock Option (right to buy)
15 Dec 2025	Form 4: Giordano Natasha, Director Granted 163,320 Non-Employee Director Option (Right to Buy)
15 Dec 2025	Form 4: Telling Fred, Director Granted 125,000 Non-Employee Director Option (Right to Buy) · Sold 210 shares ($198)
15 Dec 2025	Form 4: Gandolfo John P, Director Granted 125,000 Non-Employee Director Option (Right to Buy)
15 Dec 2025	Form 4: Dunton Alan W, Director Granted 125,000 Non-Employee Director Option (Right to Buy)
15 Dec 2025	Form 4: Pope Charles L, Director Granted 125,000 Non-Employee Director Option (Right to Buy)
15 Dec 2025	Form 4: Koski Robert C, Director Granted 125,000 Non-Employee Director Option (Right to Buy)
18 Jun 2025	Form 4: Odyssey Health, Inc., 10% owner Sold 2,000 shares ($8.92K) · Sold 5,044 shares ($21.5K)
16 Jun 2025	Form 4: Odyssey Health, Inc., 10% owner Sold 5,000 shares ($21.4K) · Sold 5,000 shares ($22.3K)
13 Dec 2024	Form 4: Koski Robert C, Director Received 5,000 shares by conversion
09 Dec 2024	Form 4: Dunton Alan W, Director Sold 66 shares ($23.8)
09 Dec 2024	Form 4: Telling Fred, Director Sold 3,597 shares ($1.29K)
20 Sep 2024	Form 4: Pope Charles L, Director Granted 100,000 Non-Employee Director Option (Right to Buy)
20 Sep 2024	Form 4: Huffman Janet, Chief Financial Officer Granted 80,000 Employee Option (Right to Buy)
20 Sep 2024	Form 4: Redmond J Michael, President Granted 100,000 Employee Option (Right to Buy)
20 Sep 2024	Form 4: Koski Robert C, Director Granted 65,000 Non-Employee Director Option (Right to Buy)
20 Sep 2024	Form 4: Gandolfo John P, Director Granted 45,000 Non-Employee Director Option (Right to Buy)
20 Sep 2024	Form 4: Dunton Alan W, Director Granted 65,000 Non-Employee Director Option (Right to Buy)
20 Sep 2024	Form 4: Cassidy Bruce A. Sr., Director Granted 45,000 Non-Employee Director Option (Right to Buy)

Comments